← Back to Search

Behavioural Intervention

CC+ECIG Condition for Substance Abuse

N/A
Recruiting
Led By Lorra Garey, Ph.D
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 1-7, 9, and 11 of participation
Awards & highlights

Study Summary

This trial will evaluate the effectiveness of a retraining program to help people quit smoking cigarettes and using electronic cigarettes. The study will follow 90 experienced users who are motivated to quit as they try to quit on their own.

Who is the study for?
This trial is for adults who've used both regular cigarettes and e-cigarettes with nicotine almost every day over the last month, can read and speak English fluently, want to quit nicotine (scoring at least 5 out of 10 in motivation), and own an Android smartphone. It's not for those currently getting treatment for mental illness or addiction, using other quitting aids like nicotine patches or certain medications, or unable to consent.Check my eligibility
What is being tested?
The study tests a 'bias training' method to help people quit smoking by comparing three groups: one uses bias training for both cigarettes and e-cigs (CC+ECIG Condition), another only for cigarettes (CC Condition), while the third group gets a fake intervention (Sham Condition). Participants are randomly assigned to these groups during their self-guided attempt to stop using nicotine.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medication, traditional side effects are not expected. However, participants may experience frustration or stress due to quitting attempts or possible cravings triggered during approach bias retraining exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 1-7, 9, and 11 of participation
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1-7, 9, and 11 of participation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Approach Bias
Biochemically-Verified Point Prevalence Abstinence
Lapse
+4 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: CC+ECIG ConditionExperimental Treatment1 Intervention
Combustible Cigarette (CC) and Electronic Cigarette (ECIG) users will be trained to avoid CC and ECIG-related images and approach positive images.
Group II: CC Only ConditionActive Control1 Intervention
Participants in this arm will be trained to avoid only combustible cigarette images, not electronic cigarettes images.
Group III: Sham ConditionPlacebo Group1 Intervention
Participants will pull and push all pictures of CC and ECIG images equally with no preference towards one or the other.

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
147 Previous Clinical Trials
47,458 Total Patients Enrolled
Lorra Garey, Ph.DPrincipal InvestigatorAssistant Research Professor

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the participant demographic for this trial limited to those over 20 years of age?

"This study is open to individuals aged 18 and up, but no older than 85."

Answered by AI

Is there still an opportunity to join in this research endeavor?

"Affirmative. According to clinicaltrials.gov, this research has been recruiting participants since October 1st 2022 and is still actively doing so at present. 90 patients are needed from a single healthcare facility for the trial to meet its goals."

Answered by AI

What is the maximum number of participants approved to join this research endeavor?

"Affirmative. Information on clinicaltrials.gov affirms that recruitment for this medical trial, which launched in October 1st 2022, is ongoing. It plans to recruit 90 people from a single site."

Answered by AI

Are there any prerequisites for participation in this clinical trial?

"This clinical trial is recruiting 90 participants aged 18-85 who are habitual nicotine users. The essential prerequisites for enrolment include: the minimum age of consent, ability to speak and read English fluently, owning an android phone (for EMA purposes), a strong desire to quit using nicotine products, and no reduction in CC or ECIG usage by more than half within the last month."

Answered by AI

Who else is applying?

What state do they live in?
West Virginia
Texas
Kansas
How old are they?
18 - 65
What site did they apply to?
RESTORE Laboratory
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
3+
0

Why did patients apply to this trial?

I want to stop vaping and smoking.
PatientReceived 2+ prior treatments

What questions have other patients asked about this trial?

Can I be in this study online?
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Dual Use Approach Bias Training for Nicotine Addiction
Lorra Garey 2022. "Dual Use Approach Bias Training for Nicotine Addiction". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05306158.
All > Substance Abuse > Addiction
~16 spots leftby Sep 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top